Skip to main content

Coeptis Therapeutics Inc.

COEPDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001819663

Coeptis Therapeutics Inc. was delisted in 2022; its insiders filed their last Form 4 on Nov 18, 2021; no institution reported holding it in 13F filings for Q3 2022; no superinvestor held it.

13F holders, Q3 2022

Institutional positions in Coeptis Therapeutics Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

COEP is no longer listed, so this page shows Q3 2022. 13F filings for later quarters list far fewer holders.

Institutional holders
0
0 vs. Q2 2022
Shares held
0
0 vs. Q2 2022
Total value
$0
$0 vs. Q2 2022
New holders
0
0 more added
Sold out
0
0 more reduced

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Coeptis Therapeutics Inc.; share changes are against Q2 2022.

No institution reported holding COEP in Q3 2022.